JP2011515481A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011515481A5 JP2011515481A5 JP2011501983A JP2011501983A JP2011515481A5 JP 2011515481 A5 JP2011515481 A5 JP 2011515481A5 JP 2011501983 A JP2011501983 A JP 2011501983A JP 2011501983 A JP2011501983 A JP 2011501983A JP 2011515481 A5 JP2011515481 A5 JP 2011515481A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cancer
- kit
- sodium meta
- cisplatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3998708P | 2008-03-27 | 2008-03-27 | |
| US61/039,987 | 2008-03-27 | ||
| US12/408,864 | 2009-03-23 | ||
| US12/408,864 US20090246291A1 (en) | 2008-03-27 | 2009-03-23 | Method and compositions for treatment of cancer |
| PCT/US2009/038104 WO2009120697A2 (en) | 2008-03-27 | 2009-03-24 | Method and compositions for treatment of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014046212A Division JP2014101387A (ja) | 2008-03-27 | 2014-03-10 | 癌の処置のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011515481A JP2011515481A (ja) | 2011-05-19 |
| JP2011515481A5 true JP2011515481A5 (https=) | 2012-04-05 |
| JP5543956B2 JP5543956B2 (ja) | 2014-07-09 |
Family
ID=41114644
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011501983A Expired - Fee Related JP5543956B2 (ja) | 2008-03-27 | 2009-03-24 | 癌の処置のための方法および組成物 |
| JP2014046212A Withdrawn JP2014101387A (ja) | 2008-03-27 | 2014-03-10 | 癌の処置のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014046212A Withdrawn JP2014101387A (ja) | 2008-03-27 | 2014-03-10 | 癌の処置のための方法および組成物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20090246291A1 (https=) |
| EP (1) | EP2268292B1 (https=) |
| JP (2) | JP5543956B2 (https=) |
| KR (1) | KR101634138B1 (https=) |
| CN (2) | CN104997808A (https=) |
| AU (1) | AU2009228378B2 (https=) |
| BR (1) | BRPI0909164A2 (https=) |
| CA (1) | CA2719766C (https=) |
| CY (1) | CY1120536T1 (https=) |
| DK (1) | DK2268292T3 (https=) |
| ES (1) | ES2656762T3 (https=) |
| HU (1) | HUE036609T2 (https=) |
| LT (1) | LT2268292T (https=) |
| MX (1) | MX2010010621A (https=) |
| PL (1) | PL2268292T3 (https=) |
| PT (1) | PT2268292T (https=) |
| RU (1) | RU2508116C2 (https=) |
| SI (1) | SI2268292T1 (https=) |
| WO (1) | WO2009120697A2 (https=) |
| ZA (1) | ZA201006988B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| PT2475362T (pt) * | 2009-09-10 | 2019-05-27 | Kominox Inc | Terapia especifica para celulas estaminais cancerigenas e para 0 cancro resistente a medicamentos |
| US8795738B2 (en) * | 2009-11-12 | 2014-08-05 | Board Of Regents Of The University Of Texas System | Use of arsenic for cancer therapy protection |
| US11084811B2 (en) | 2010-03-01 | 2021-08-10 | Oncternal Therapeutics, Inc. | Compounds for treatment of cancer |
| CN103153303A (zh) * | 2010-07-18 | 2013-06-12 | 尼基制药公司 | 使用钌络合物的联合疗法 |
| ES2718637T3 (es) * | 2010-08-24 | 2019-07-03 | Gtx Inc | Compuestos para el tratamiento del cáncer |
| US20120251628A1 (en) * | 2011-03-30 | 2012-10-04 | Young Joo Min | Compositions and methods for treatment of cancer |
| CN103826645A (zh) * | 2011-05-12 | 2014-05-28 | 得克萨斯系统大学评议会 | 砷在癌症治疗保护中的用途 |
| US8834938B2 (en) | 2011-05-18 | 2014-09-16 | Board Of Regents Of The University Of Texas System | Use of arsenic for cancer therapy protection |
| KR101309844B1 (ko) | 2013-03-15 | 2013-09-23 | 박상채 | 항암 활성 증진용 한약재 및 이의 제조방법 |
| WO2014152330A1 (en) * | 2013-03-15 | 2014-09-25 | Stc.Unm | Arsenic-based treatment of cancers and inflammatory disorders |
| MX372671B (es) * | 2013-07-19 | 2020-04-23 | Onyx Therapeutics Inc | Inhibidores de proteasoma de epoxicetona peptídica en combinacion con inhibidores de cinasa pim para el tratamiento de canceres. |
| ES2964979T3 (es) | 2016-12-01 | 2024-04-10 | Eupharma Pty Ltd | Composiciones de arsénico |
| AU2019239671B2 (en) | 2018-03-22 | 2025-02-27 | Komipharm International Australia Pty Ltd | Pharmaceutical composition comprising meta arsenite and method of manufacture |
| CN116236505A (zh) * | 2023-03-15 | 2023-06-09 | 上海市第四人民医院 | 三氧化二砷在制备肺神经内分泌癌治疗药物中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001519366A (ja) * | 1997-10-15 | 2001-10-23 | ポーラクス バイオファーマシュティカルズ，インコーポレーテッド | ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法 |
| IL136051A0 (en) * | 1997-11-10 | 2001-05-20 | Sloan Kettering Inst Cancer | Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| KR20020083678A (ko) * | 2001-04-28 | 2002-11-04 | 주식회사 한국미생물연구소 | 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물 |
| EP1496918B1 (en) * | 2002-04-10 | 2023-02-08 | Komipharm International Co., Ltd. | Use of sodium meta-arsenite for the treatment of tumours |
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US8097237B2 (en) * | 2005-08-23 | 2012-01-17 | Stc.Unm | Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma |
| US7867492B2 (en) * | 2007-10-12 | 2011-01-11 | The John Hopkins University | Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies |
-
2009
- 2009-03-23 US US12/408,864 patent/US20090246291A1/en not_active Abandoned
- 2009-03-24 RU RU2010143893/15A patent/RU2508116C2/ru active
- 2009-03-24 DK DK09723788.7T patent/DK2268292T3/en active
- 2009-03-24 WO PCT/US2009/038104 patent/WO2009120697A2/en not_active Ceased
- 2009-03-24 MX MX2010010621A patent/MX2010010621A/es active IP Right Grant
- 2009-03-24 CN CN201510355863.5A patent/CN104997808A/zh active Pending
- 2009-03-24 JP JP2011501983A patent/JP5543956B2/ja not_active Expired - Fee Related
- 2009-03-24 AU AU2009228378A patent/AU2009228378B2/en not_active Ceased
- 2009-03-24 CN CN2009801187686A patent/CN102046187A/zh active Pending
- 2009-03-24 EP EP09723788.7A patent/EP2268292B1/en active Active
- 2009-03-24 BR BRPI0909164A patent/BRPI0909164A2/pt not_active Application Discontinuation
- 2009-03-24 LT LTEP09723788.7T patent/LT2268292T/lt unknown
- 2009-03-24 KR KR1020107024132A patent/KR101634138B1/ko not_active Expired - Fee Related
- 2009-03-24 PT PT97237887T patent/PT2268292T/pt unknown
- 2009-03-24 CA CA2719766A patent/CA2719766C/en active Active
- 2009-03-24 HU HUE09723788A patent/HUE036609T2/hu unknown
- 2009-03-24 SI SI200931809T patent/SI2268292T1/en unknown
- 2009-03-24 PL PL09723788T patent/PL2268292T3/pl unknown
- 2009-03-24 ES ES09723788.7T patent/ES2656762T3/es active Active
-
2010
- 2010-09-30 ZA ZA2010/06988A patent/ZA201006988B/en unknown
-
2014
- 2014-03-10 JP JP2014046212A patent/JP2014101387A/ja not_active Withdrawn
-
2017
- 2017-06-02 US US15/613,020 patent/US20180055812A1/en not_active Abandoned
-
2018
- 2018-03-09 CY CY20181100285T patent/CY1120536T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011515481A5 (https=) | ||
| RU2010143893A (ru) | Способ и композиции для лечения рака | |
| JP2013527232A5 (https=) | ||
| NZ708506A (en) | Methods of treating bladder cancer | |
| JP2014528423A5 (https=) | ||
| JP2014532704A5 (https=) | ||
| JP2021512121A5 (https=) | ||
| NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
| JP2014040437A5 (https=) | ||
| NZ597830A (en) | Methods and compositions for treating cancer comprising abiraterone acetate and prednisone | |
| JP2016536361A5 (https=) | ||
| JP2011079858A5 (https=) | ||
| JP2009545601A5 (https=) | ||
| ME02470B (me) | Nanočesтice nabijene sa hemoterapeutskim anтitumorskim lekom | |
| JP2009515901A5 (https=) | ||
| MX2010009782A (es) | Tratamientos antitumorales mejorados. | |
| JP2015507020A5 (https=) | ||
| JP2016530291A5 (https=) | ||
| JP2009506054A5 (https=) | ||
| JP2011520846A5 (https=) | ||
| JP2008524329A5 (https=) | ||
| CA2672839A1 (en) | Treatment of lung cancer with s-farnesylthiosalicylic acid and analogs thereof | |
| JP2015512420A5 (https=) | ||
| JP2017516827A5 (https=) | ||
| MX2010004350A (es) | Metodos de uso del acido (+)-1,4-dihidro-7-[(3s,4s)]-3-metoxi-4-(m etilamino)-1-pirrolidinil-4-oxo-1-(2-tiazolil)-1, 8-naftiridina-3-carboxilico en terapias de combinacion. |